Healthy
Showing NaN - NaN of 135
Healthy Trial in New Haven (PF 06260414 solid dose formulation, PF-06260414 nanosuspension)
Withdrawn
- Healthy
- PF 06260414 solid dose formulation
- PF-06260414 nanosuspension
-
New Haven, ConnecticutPfizer New Haven Clinical Research Unit
Nov 12, 2018
Healthy Trial in New Haven (PF-06260414, Placebo)
Completed
- Healthy
- PF-06260414
- Placebo
-
New Haven, ConnecticutNew Haven Clinical Research Unit
Nov 12, 2018
A Randomized, Two-way, Crossover Study to Estimate Relative
Completed
- Healthy
- Oxycodone controlled-release test formulation
- Immediate-release reference drug
-
New Haven, ConnecticutPfizer Investigational Site
Sep 26, 2018
Healthy Trial in New Haven (ALO-02 (Oxycodone Naltrexone))
Completed
- Healthy
- ALO-02 (Oxycodone Naltrexone)
-
New Haven, ConnecticutPfizer Investigational Site
Sep 26, 2018
Healthy Trial in New Haven (Epoetin Hospira SDV, Epoetin Hospira MDV)
Completed
- Healthy
- Epoetin Hospira SDV
- Epoetin Hospira MDV
-
New Haven, ConnecticutPfizer New Haven Clinical Research Unit
May 16, 2018
Healthy Trial in New Haven (PF-06650833, Placebo)
Completed
- Healthy
- PF-06650833
- Placebo
-
New Haven, ConnecticutPfizer New Haven Clinical Research Unit
Apr 17, 2018
Healthy Trial in New Haven (10 mg dose MR formulations,10 mg dose of tofacitinib IR solution)
Completed
- Healthy
- 10 mg dose MR formulations,10 mg dose of tofacitinib IR solution
-
New Haven, ConnecticutPfizer New Haven Clinical Research Unit
Jan 20, 2018
Healthy Trial in New Haven (Placebo, PF-06818883)
Terminated
- Healthy
- Placebo
- PF-06818883
-
New Haven, ConnecticutPfizer New Haven Clinical Research Unit
Dec 7, 2017
Healthy Trial in New Haven (PF-06823859, Placebo injection SC/IV)
Completed
- Healthy
- PF-06823859
- Placebo injection SC/IV
-
New Haven, ConnecticutPfizer New Haven Clinical Research Unit
Nov 13, 2017
Healthy Trial in New Haven (Crizotinib, Esomeprazole)
Completed
- Healthy
-
New Haven, ConnecticutPfizer New Haven Clinical Research Unit
Oct 27, 2017
Healthy Trial in New Haven (tafamidis)
Completed
- Healthy
-
New Haven, ConnecticutPfizer New Haven Clinical Research Unit
Sep 26, 2017
Healthy Trial in New Haven (PF-06865571, Placebo)
Completed
- Healthy
- PF-06865571
- Placebo
-
New Haven, ConnecticutPfizer New Haven Clinical Research Unit
Aug 10, 2017
Healthy Trial in New Haven (Fluoxetine, Zolpidem, Progesterone)
Completed
- Healthy
- Fluoxetine
- +2 more
-
New Haven, ConnecticutYale University School of Medicine; Yale Program for Women's Rep
May 25, 2017
Healthy Trial in New Haven (PF-06648671, Itraconazole)
Completed
- Healthy
-
New Haven, ConnecticutPfizer New Haven Clinical Research Unit
Dec 19, 2016
Healthy Trial in New Haven (PF-06480605, Placebo)
Completed
- Healthy
- PF-06480605
- Placebo
-
New Haven, ConnecticutNew Haven Clinical Research Unit
Apr 29, 2016
Healthy Trial in New Haven (PF-05230907, Placebo)
Completed
- Healthy
- PF-05230907
- Placebo
-
New Haven, ConnecticutPfizer New Haven Clinical Research Unit
Apr 28, 2016
Healthy Trial in New Haven (PD-0332991 alone, Tamoxifen 60 mg, Tamoxifen 20 mg)
Completed
- Healthy
- PD-0332991 alone
- +3 more
-
New Haven, ConnecticutPfizer Investigational Site
Oct 6, 2015
Healthy Trial in New Haven (PF-04856883)
Completed
- Healthy
- PF-04856883
-
New Haven, ConnecticutNew Haven Clinical Research Unit
Jul 30, 2015